IDH1突变降低星形细胞肿瘤微血管周细胞覆盖
本研究通过MRI测量脑血流量、免疫组化标记微血管与周细胞、构建IDH1突变敲入小鼠及分析TCGA数据,发现IDH突变胶质瘤血流减低、周细胞覆盖显著减少而微血管密度仅轻度降低,机制为血管生成因子表达受抑。
要点
- IDH突变胶质瘤脑血流量较IDH野生型降低
- IDH突变胶质瘤微血管周细胞覆盖显著减少,微血管密度仅轻度降低
- IDH突变通过抑制ANGPT1、PDGFB、VEGFA表达减少周细胞覆盖
核心结论
- IDH突变通过抑制血管生成因子表达,降低星形细胞肿瘤微血管的周细胞覆盖。
研究设计与样本
- 采用MRI测量IDH突变与野生型胶质瘤的脑血流量并进行比较。
- 用CD34免疫组化评估微血管密度,用α-SMA、NG2和PDGFR-β标记周细胞。
- 构建胶质细胞特异性IDH1突变敲入小鼠评估脑血管架构。
- 分析TCGA数据集血管生成相关基因转录,并在U87-MG细胞中验证蛋白表达。
主要发现
- MRI显示IDH突变胶质瘤的脑血流量降低。
- 免疫组化显示IDH突变胶质瘤微血管周细胞覆盖显著减少,微血管密度仅轻度降低。
- IDH1突变敲入小鼠脑微血管周细胞覆盖亦受损。
- TCGA数据库显示IDH突变胶质瘤中ANGPT1、PDGFB和VEGFA的mRNA水平下调,其启动子高度超甲基化。
- 突变IDH1和D-2-HG均可下调U87-MG细胞中上述基因的表达。
临床怎么用
- IDH突变胶质瘤抗血管生成治疗策略需考虑周细胞覆盖减少的血管特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tumour-associated angiogenesis is associated with the malignancy and poor prognosis of glioma. Isocitrate dehydrogenase (IDH) mutations are present in the majority of lower-grade (WHO grade II and III) and secondary glioblastomas, but their roles in tumour angiogenesis remain unclear. METHODS: Using magnetic resonance imaging (MRI), the cerebral blood flow (CBF) of IDH-mutated glioma was measured and compared with the IDH-wildtype glioma. The densities of microvessels in IDH-mutated and wildtype astrocytoma and glioblastoma were assessed by immunohistochemical (IHC) staining with CD34, and the pericytes were labelled with α-smooth muscle antigen (α-SMA), neural-glial antigen 2 (NG2) and PDGF receptor-β (PDGFR-β), respectively. Furthermore, glia-specific mutant IDH1 knock-in mice were generated to evaluate the roles of mutant IDH1 on brain vascular architectures. The transcriptions of the angiogenesis-related genes were assessed in TCGA datasets, including ANGPT1, PDGFB and VEGFA. The expressions of these genes were further determined by western blot in U87-MG cells expressing a mutant IDH1 or treated with 2-HG. RESULTS: The MRI results indicated that CBF was reduced in the IDH-mutated gliomas. The IHC staining showed that the pericyte coverages of microvessels were significantly decreased, but the microvessel densities (MVDs) were only slightly decreased in IDH-mutated glioma. The mutant IDH1 knock-in also impeded the pericyte coverage of brain microvessels in mice. Moreover, the TCGA database showed the mRNA levels of angiogenesis factors, including ANGPT1, PDGFB and VEGFA, were downregulated, and their promoters were also highly hyper-methylated in IDH-mutated gliomas. In addition, both mutant IDH1 and D-2-HG could downregulate the expression of these genes in U87-MG cells. CONCLUSIONS: Our results suggested that IDH mutations could reduce the pericyte coverage of microvessels in astrocytic tumours by inhibiting the expression of angiogenesis factors. As vascular pericytes play an essential role in maintaining functional blood vessels to support tumour growth, our findings imply a potential avenue of therapeutic strategy for IDH-mutated gliomas.
引用
- Sun C, Zhao Y, Shi J, et al. Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours. J Neurooncol. 2019. PMID: 31004262. doi:10.1007/s11060-019-03156-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。